Schramm Andrea, Schweda Frank, Sequeira-Lopez Maria Luisa S, Hofmann Franz, Sandner Peter, Schlossmann Jens
Institute of Pharmacy, Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
Institute of Physiology, University of Regensburg, Regensburg, Germany.
Front Pharmacol. 2019 Jul 18;10:800. doi: 10.3389/fphar.2019.00800. eCollection 2019.
Pharmacological inhibition of the renin-angiotensin-aldosterone system (RAAS) is, in combination with diuretics, the first-choice treatment for hypertension, although 10-20% of patients do not respond adequately. Next to the RAAS, the nitric oxide/cGMP/protein kinase G (PKG) system is the second fundamental blood pressure regulator. Whether both systems influence each other is not well-studied. It has been shown that nitric oxide (NO) supports renin recruitment activation of soluble guanylate cyclase (sGC) and subsequent generation of cGMP. Whether this leads to an ensuing activation of PKGs in this context is not known. PKGIα, as well as PKGII, is expressed in renin-producing cells. Hence, we analyzed whether these enzymes play a role regarding renin synthesis, secretion, or recruitment. We generated renin-cell-specific PKGI-knockout mice and either stimulated or inhibited the renin system in these mice by salt diets. To exclude the possibility that one kinase isoform can compensate the lack of the other, we also studied double-knockout animals with a conditional knockout of PKGI in juxtaglomerular cells (JG cells) and a ubiquitous knockout of PKGII. We analyzed blood pressure, renin mRNA and renal renin protein content as well as plasma renin concentration. Furthermore, we stimulated the cGMP system in these mice using BAY 41-8543, an sGC stimulator, and examined renin regulation either after acute administration or after 7 days (application once daily). We did not reveal any striking differences regarding long-term renin regulation in the studied mouse models. Yet, when we studied the acute effect of BAY 41-8543 on renin secretion in isolated perfused kidneys as well as in living animals, we found that the administration of the substance led to a significant increase in plasma renin concentration in control animals. This effect was completely abolished in double-knockout animals. However, after 7 days of once daily application, we did not detect a persistent increase in renin mRNA or protein in any studied genotype. Therefore, we conclude that in mice, cGMP and PKG are involved in the acute regulation of renin release but have no influence on long-term renin adjustment.
肾素 - 血管紧张素 - 醛固酮系统(RAAS)的药理抑制与利尿剂联合使用,是高血压的首选治疗方法,尽管10% - 20%的患者反应不佳。除RAAS外,一氧化氮/cGMP/蛋白激酶G(PKG)系统是第二个重要的血压调节系统。这两个系统是否相互影响尚未得到充分研究。研究表明,一氧化氮(NO)支持肾素募集、可溶性鸟苷酸环化酶(sGC)的激活以及随后cGMP的生成。在这种情况下,这是否会导致PKG的后续激活尚不清楚。PKGIα以及PKGII在肾素产生细胞中表达。因此,我们分析了这些酶在肾素合成、分泌或募集中是否起作用。我们构建了肾素细胞特异性PKGI基因敲除小鼠,并通过盐饮食刺激或抑制这些小鼠的肾素系统。为了排除一种激酶亚型可以补偿另一种激酶缺失的可能性,我们还研究了肾小球旁细胞(JG细胞)中PKGI条件性敲除和PKGII全身性敲除的双基因敲除动物。我们分析了血压、肾素mRNA、肾脏肾素蛋白含量以及血浆肾素浓度。此外,我们使用sGC刺激剂BAY 41 - 8543刺激这些小鼠的cGMP系统,并在急性给药后或7天(每天给药一次)后检查肾素调节情况。在研究的小鼠模型中,我们未发现长期肾素调节方面有任何显著差异。然而,当我们研究BAY 41 - 8543对分离灌注肾脏以及活体动物中肾素分泌的急性作用时,我们发现该物质的给药导致对照动物血浆肾素浓度显著增加。在双基因敲除动物中,这种作用完全消失。然而,在每天给药一次7天后,我们在任何研究的基因型中均未检测到肾素mRNA或蛋白的持续增加。因此,我们得出结论,在小鼠中,cGMP和PKG参与肾素释放的急性调节,但对肾素的长期调节没有影响。